Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer
Authors
Keywords
Ascites, Cholesterol, Chemoresistance, LXRα/β,, Ovarian cancer
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-12-10
DOI
10.1186/s12885-018-5152-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Liver X receptor α (LXRα) promoted invasion and EMT of gastric cancer cells by regulation of NF-κB activity
- (2017) Linhua Ji et al. Human Cell
- ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
- (2016) Aparajitha Vaidyanathan et al. BRITISH JOURNAL OF CANCER
- Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
- (2016) Soochi Kim et al. CANCER SCIENCE
- Can advanced-stage ovarian cancer be cured?
- (2016) Steven Narod Nature Reviews Clinical Oncology
- Gene expression of membrane transporters: Importance for prognosis and progression of ovarian carcinoma
- (2016) KATERINA ELSNEROVA et al. ONCOLOGY REPORTS
- Cholesterol reduces the sensitivity to platinum-based chemotherapy via upregulating ABCG2 in lung adenocarcinoma
- (2015) Yufeng Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer
- (2015) Jessica E. Stine et al. Oncotarget
- Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells
- (2015) Lihong Mo et al. PLoS One
- Statins inhibit ABCB1 and ABCG2 drug transporter activity in chronic myeloid leukemia cells and potentiate antileukemic effects of imatinib
- (2014) Eliza Glodkowska-Mrowka et al. EXPERIMENTAL HEMATOLOGY
- Effect of statin on risk of gynecologic cancers: A meta-analysis of observational studies and randomized controlled trials
- (2014) Yanqiong Liu et al. GYNECOLOGIC ONCOLOGY
- Proteome–Metabolome Profiling of Ovarian Cancer Ascites Reveals Novel Components Involved in Intercellular Communication
- (2014) Victoria O. Shender et al. MOLECULAR & CELLULAR PROTEOMICS
- Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma
- (2014) Naoshad Mohammad et al. Molecular Cancer
- Sterols and oxysterols in immune cell function
- (2013) Nathanael J Spann et al. NATURE IMMUNOLOGY
- Getting to Know Ovarian Cancer Ascites: Opportunities for Targeted Therapy-Based Translational Research
- (2013) Nuzhat Ahmed et al. Frontiers in Oncology
- Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance
- (2012) Karthika Natarajan et al. BIOCHEMICAL PHARMACOLOGY
- Cholesterol and prostate cancer
- (2012) Kristine Pelton et al. CURRENT OPINION IN PHARMACOLOGY
- Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
- (2011) Denis Lane et al. BMC CANCER
- Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and Regulation
- (2010) C. D. Klaassen et al. PHARMACOLOGICAL REVIEWS
- Synergistic effect of interleukin-6 and endoplasmic reticulum stress inducers on the high level of ABCG2 expression in plasma cells
- (2009) Naoto Nakamichi et al. LABORATORY INVESTIGATION
- Ins and outs of the ABCG2 multidrug transporter: An update on in vitro functional assays
- (2008) Csilla Hegedűs et al. ADVANCED DRUG DELIVERY REVIEWS
- Statin use and female reproductive organ cancer risk in a large population-based setting
- (2008) Onchee Yu et al. CANCER CAUSES & CONTROL
- Impact of statin therapy on survival in epithelial ovarian cancer
- (2008) R. Geoffrey Elmore et al. GYNECOLOGIC ONCOLOGY
- Cellular cholesterol trafficking and compartmentalization
- (2008) Elina Ikonen NATURE REVIEWS MOLECULAR CELL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started